SEC Form 4 · accession 0001513162-16-000787
Anixa Biosciences Inc · ANIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bruce F Johnson
Director
Period of report
Mar 31, 2016
Accepted (ET)
Apr 4, 2016 · 12:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000715446
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 31, 2016 | P | 500 | $3.01 | A | 406,905 | D | |
| Common Stock | Mar 31, 2016 | P | 100 | $3.02 | A | 407,005 | D |
Table II — derivative securities
No Table II lines on this filing.